On EEGabout 80% showed non-paroxysmal abnormalities. This was evident in 90% of cases with optic-spinal form with or without cerebral signs. of the demyelinating factor12). By using the rabbits sensitized with spinal cord, injection of MBPin the eyes produced the demeylination of the myelinated fibers on the ratina. With the use of various control studies, a conclusion was made that the MBPsensitized cells get in contact with the MBP, thereby producing a demyelinating factor at the site. MBP,therefore, was revealed to act as the encephalitogen, target, and trigger factor at the site of the demyelinating lesion.
About the encephalitogenic MBP,Nagai made the smallest model of EAE with 7 aminoacids and synthetic adjuvant. This EAE, however, is only an acute monophasic one.
Chronic Relapsing EAE :
Tabira confirmed the production of chronic relapsing EAE by using juvenile Strain 13 guinea pigs and the whole spinal cord as the encephalitogen.
The animals showedtypical remissions and exacerbations with long latency period of about 2-3 months and relapses developed for as long as one year during the observation period. The pathology showed the demyelinating plaques instead of perivascular lesions of acute EAE.
Since the endephalitogenic MBPcould not produce a chronic course, this gives a suggestion that probably a plus alpha is needed in addition to MBP. Therefore, if human MSis caused by an encephalitogen (antigen), 
